Esomeprazole, Candesartan And Pravastatin Tablets: Oos Result For Finished Product Assay And/or Blend Uniformity
Recall Summary Taro Pharmaceuticals is recalling four medications (Taro-Esomeprazole 20mg and 40mg, Taro-Candesartan, and Taro-Pravastatin) across Canada due to failed quality testing for active ingredient content and uniformity in batches. The products did not meet required standards for the amount of medication in each tablet. This recall affects all Canadian patients who have these medications.
- Product
- TARO-ESOMEPRAZOLE 20MG, TARO-ESOMEPRAZOLE 40MG, TARO-CANDESARTAN, TARO-PRAVASTATIN
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2022-09-21
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/86c6ffc8-6ba1-485c-8136-b0619a2e287b